Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Association of Plasma Concentration of Vitamin B12 With All-Cause Mortality in the General Population in the Netherlands.

Flores-Guerrero JL, Minovic I, Groothof D, Gruppen EG, Riphagen IJ, Kootstra-Ros J, Muller Kobold A, Hak E, Navis G, Gansevoort RT, de Borst MH, Dullaart RPF, Bakker SJL.

JAMA Netw Open. 2020 Jan 3;3(1):e1919274. doi: 10.1001/jamanetworkopen.2019.19274.

PMID:
31940038
2.
3.

Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients.

Douwes RM, Gomes-Neto AW, Schutten JC, van den Berg E, de Borst MH, Berger SP, Touw DJ, Hak E, Blokzijl H, Navis G, Bakker SJL.

J Clin Med. 2019 Dec 6;8(12). pii: E2162. doi: 10.3390/jcm8122162.

4.

Pharmacy-based predictors of non-adherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the Netherlands.

Alfian SD, Denig P, Coelho A, Hak E.

PLoS One. 2019 Nov 15;14(11):e0225390. doi: 10.1371/journal.pone.0225390. eCollection 2019.

5.

Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study.

Gruppen EG, Kootstra-Ros J, Kobold AM, Connelly MA, Touw D, Bos JHJ, Hak E, Links TP, Bakker SJL, Dullaart RPF.

Endocrine. 2019 Nov 9. doi: 10.1007/s12020-019-02125-2. [Epub ahead of print]

PMID:
31707605
6.

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial).

van der Schans J, Hak E, Postma M, Breuning L, Brouwers JRBJ, Ditters K, Jansen PAF, Kok RM, Maring JG, van Marum R, Mulder H, Nanninga J, Oude Voshaar RC, Risselada AJ, Vleugel L, Stek M, van Schaik RHN, Berm EJJ, Wilffert B.

J Clin Psychopharmacol. 2019 Nov/Dec;39(6):583-590. doi: 10.1097/JCP.0000000000001129.

PMID:
31688392
7.

A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy.

Sluiter MN, de Vries YA, Koning LG, Hak E, Bos JHJ, Schuiling-Veninga CCM, Batstra L, Doornenbal JM, de Jonge P.

Adm Policy Ment Health. 2019 Oct 16. doi: 10.1007/s10488-019-00983-6. [Epub ahead of print]

PMID:
31620909
8.

A Retrospective Surveillance of the Antibiotics Prophylactic Use of Surgical Procedures in Private Hospitals in Indonesia.

Herawati F, Yulia R, Hak E, Hartono AH, Michiels T, Woerdenbag HJ, Avanti C.

Hosp Pharm. 2019 Oct;54(5):323-329. doi: 10.1177/0018578718792804. Epub 2018 Aug 21.

PMID:
31555008
9.

Patients' Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial.

Edelman M, Jellema P, Hak E, Denig P, Blanker MH.

Drugs Aging. 2019 Dec;36(12):1133-1139. doi: 10.1007/s40266-019-00712-6.

10.

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients.

Douwes RM, Gomes-Neto AW, Eisenga MF, Vinke JSJ, de Borst MH, van den Berg E, Berger SP, Touw DJ, Hak E, Blokzijl H, Navis G, Bakker SJL.

J Clin Med. 2019 Sep 3;8(9). pii: E1382. doi: 10.3390/jcm8091382.

11.

Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.

Pradipta IS, Van't Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar JC, Hak E.

Antimicrob Resist Infect Control. 2019 Jul 12;8:115. doi: 10.1186/s13756-019-0561-z. eCollection 2019.

12.

Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions.

Scholl JHG, van Hunsel FPAM, Hak E, van Puijenbroek EP.

Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1283-1289. doi: 10.1002/pds.4790. Epub 2019 Jun 12.

13.

No significant association of type 2 diabetes-related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives.

Martono DP, Heerspink HJL, Hak E, Denig P, Wilffert B.

Diabetes Obes Metab. 2019 Oct;21(10):2267-2273. doi: 10.1111/dom.13803. Epub 2019 Jun 24.

14.

Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA.

Cochrane Database Syst Rev. 2019 May 28;5:CD001480. doi: 10.1002/14651858.CD001480.pub5.

PMID:
31135969
15.
16.

The temporal order of fluctuations in atopic disease symptoms and attention-deficit/hyperactivity disorder symptoms: a time-series study in ADHD patients.

van der Schans J, Cao Q, Bos EH, Rours GIJG, Hoekstra PJ, Hak E, de Vries TW.

Eur Child Adolesc Psychiatry. 2019 Apr 24. doi: 10.1007/s00787-019-01336-2. [Epub ahead of print]

PMID:
31020405
17.

Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States.

Oktora MP, Denig P, Bos JHJ, Schuiling-Veninga CCM, Hak E.

PLoS One. 2019 Mar 22;14(3):e0214240. doi: 10.1371/journal.pone.0214240. eCollection 2019.

18.

A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications.

Alfian SD, Pradipta IS, Hak E, Denig P.

J Clin Epidemiol. 2019 Apr;108:44-53. doi: 10.1016/j.jclinepi.2018.12.003. Epub 2018 Dec 8. Review.

19.

Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: A systematic review.

Idema DL, Wang Y, Biehl M, Horvatovich PL, Hak E.

PLoS One. 2018 Dec 6;13(12):e0208389. doi: 10.1371/journal.pone.0208389. eCollection 2018.

20.

Continuation rates of alpha-blockers mono-therapy in adult men, prescribed by urologists or general practitioners: a pharmacy-based study.

Hordijk IMJ, Steffens MG, Hak E, Blanker MH.

World J Urol. 2019 Aug;37(8):1659-1664. doi: 10.1007/s00345-018-2557-3. Epub 2018 Nov 13.

21.

Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study.

Pradipta IS, Van't Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar JWC, Hak E.

Clin Microbiol Infect. 2019 Jun;25(6):761.e1-761.e7. doi: 10.1016/j.cmi.2018.10.009. Epub 2018 Oct 27.

PMID:
30394362
22.

Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.

Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW.

J Infect. 2018 Dec;77(6):469-478. doi: 10.1016/j.jinf.2018.10.004. Epub 2018 Oct 16.

PMID:
30339803
23.

The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine.

Bahar MA, Kamp J, Borgsteede SD, Hak E, Wilffert B.

Br J Clin Pharmacol. 2018 Dec;84(12):2704-2715. doi: 10.1111/bcp.13741. Epub 2018 Sep 24.

24.

Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.

Wang Y, Zijp TR, Bahar MA, Kocks JWH, Wilffert B, Hak E.

J Antimicrob Chemother. 2018 Dec 1;73(12):3231-3243. doi: 10.1093/jac/dky326.

PMID:
30189002
25.

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative.

Sediq R, van der Schans J, Dotinga A, Alingh RA, Wilffert B, Bos JH, Schuiling-Veninga CC, Hak E.

Clin Epidemiol. 2018 Aug 16;10:981-989. doi: 10.2147/CLEP.S163037. eCollection 2018.

26.

Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies.

Irawati S, Wasir R, Floriaan Schmidt A, Islam A, Feenstra T, Buskens E, Wilffert B, Hak E.

Curr Med Res Opin. 2019 Feb;35(2):291-299. doi: 10.1080/03007995.2018.1491149. Epub 2018 Jul 30.

PMID:
29920124
27.

Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study.

Zakiyah N, Ter Heijne LF, Bos JH, Hak E, Postma MJ, Schuiling-Veninga CCM.

BMC Pregnancy Childbirth. 2018 May 29;18(1):187. doi: 10.1186/s12884-018-1825-y.

28.

Response.

van der Schans J, Hak E, Hoekstra PJ, de Vries TW.

Chest. 2018 May;153(5):1280-1281. doi: 10.1016/j.chest.2018.02.009. No abstract available.

PMID:
29731042
29.

The potential economic value of influenza vaccination for healthcare workers in The Netherlands.

Meijboom MJ, Riphagen-Dalhuisen J, Hak E.

Influenza Other Respir Viruses. 2018 Jul;12(4):457-464. doi: 10.1111/irv.12558. Epub 2018 May 24.

30.

Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.

Bahar MA, Wang Y, Bos JHJ, Wilffert B, Hak E.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):621-629. doi: 10.1002/pds.4422. Epub 2018 Mar 24.

31.

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.

Thorrington D, van Rossum L, Knol M, de Melker H, Rümke H, Hak E, van Hoek AJ.

PLoS One. 2018 Feb 9;13(2):e0192640. doi: 10.1371/journal.pone.0192640. eCollection 2018.

32.

Risks versus benefits of medication use during pregnancy: what do women perceive?

Mulder B, Bijlsma MJ, Schuiling-Veninga CC, Morssink LP, van Puijenbroek E, Aarnoudse JG, Hak E, de Vries TW.

Patient Prefer Adherence. 2017 Dec 20;12:1-8. doi: 10.2147/PPA.S146091. eCollection 2018.

33.

Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands.

Alfian SD, Worawutputtapong P, Schuiling-Veninga CCM, van der Schans J, Bos JHJ, Hak E, Denig P.

Curr Med Res Opin. 2018 Jun;34(6):1013-1019. doi: 10.1080/03007995.2017.1417242. Epub 2018 Jan 15.

PMID:
29292657
34.

A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands.

Scholl JHG, van Hunsel FPAM, Hak E, van Puijenbroek EP.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):199-205. doi: 10.1002/pds.4364. Epub 2017 Dec 21.

35.

[Upward trend in the use of psychostimulants by adults].

van der Koog L, van der Schans J, Tjioe MA, Bos JHJ, Bijker BJ, Hak E, Schuiling-Veninga CCM.

Ned Tijdschr Geneeskd. 2017;161:D1660. Dutch.

PMID:
29098969
36.

Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study.

Nguyen T, Le KK, Cao HTK, Tran DTT, Ho LM, Thai TND, Pham HTK, Pham PT, Nguyen TH, Hak E, Pham TT, Taxis K.

BMJ Open. 2017 Oct 5;7(10):e017008. doi: 10.1136/bmjopen-2017-017008.

37.

Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study.

Daud ANA, Bergman JEH, Kerstjens-Frederikse WS, van der Vlies P, Hak E, Berger RMF, Groen H, Wilffert B.

Pharmacogenomics. 2017 Jul;18(10):987-1001. doi: 10.2217/pgs-2017-0036. Epub 2017 Jun 22.

38.

Association Between Attention-Deficit/Hyperactivity Disorder and Asthma Among Adults: A Case-Control Study.

van der Schans J, Aikman B, de Vries TW, Hoekstra PJ, Hak E.

Chest. 2017 Jun;151(6):1406-1407. doi: 10.1016/j.chest.2017.03.052. No abstract available.

PMID:
28599940
39.

[Effectiveness of influenza vaccine in the Netherlands: predominant circulating virus type and vaccine match are important conditions].

van Doorn E, Darvishian M, Dijkstra F, Bijlsma MJ, Donker GA, de Lange MMA, Cadenau LM, Hak E, Meijer A.

Ned Tijdschr Geneeskd. 2017;161:D1648. Dutch.

PMID:
28558853
40.

Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.

Bahar MA, Setiawan D, Hak E, Wilffert B.

Pharmacogenomics. 2017 May;18(7):701-739. doi: 10.2217/pgs-2017-0194. Epub 2017 May 8. Review.

PMID:
28480783
41.

Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.

van Doorn E, Darvishian M, Dijkstra F, Donker GA, Overduin P, Meijer A, Hak E.

Vaccine. 2017 May 15;35(21):2831-2839. doi: 10.1016/j.vaccine.2017.04.012. Epub 2017 Apr 12.

42.

Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.

Daud ANA, Bergsma EL, Bergman JEH, De Walle HEK, Kerstjens-Frederikse WS, Bijker BJ, Hak E, Wilffert B.

BMC Pregnancy Childbirth. 2017 Apr 14;17(1):120. doi: 10.1186/s12884-017-1290-z.

43.

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.

van Doorn E, Pleguezuelos O, Liu H, Fernandez A, Bannister R, Stoloff G, Oftung F, Norley S, Huckriede A, Frijlink HW, Hak E.

BMC Infect Dis. 2017 Apr 4;17(1):241. doi: 10.1186/s12879-017-2341-9.

44.

Methylphenidate use and school performance among primary school children: a descriptive study.

van der Schans J, Çiçek R, Vardar S, Bos JH, de Vries TW, Hoekstra PJ, Hak E.

BMC Psychiatry. 2017 Mar 29;17(1):116. doi: 10.1186/s12888-017-1279-1.

45.

The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly.

Bahar MA, Hak E, Bos JHJ, Borgsteede SD, Wilffert B.

Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):752-765. doi: 10.1002/pds.4200. Epub 2017 Mar 26.

PMID:
28345306
46.

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.

van Doorn E, Liu H, Ben-Yedidia T, Hassin S, Visontai I, Norley S, Frijlink HW, Hak E.

Medicine (Baltimore). 2017 Mar;96(11):e6339. doi: 10.1097/MD.0000000000006339.

47.

Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.

Daud AN, Bergman JE, Oktora MP, Kerstjens-Frederikse WS, Groen H, Bos JH, Hak E, Wilffert B.

PLoS One. 2017 Mar 13;12(3):e0173530. doi: 10.1371/journal.pone.0173530. eCollection 2017.

48.

Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.

Darvishian M, van den Heuvel ER, Bissielo A, Castilla J, Cohen C, Englund H, Gefenaite G, Huang WT, la Bastide-van Gemert S, Martinez-Baz I, McAnerney JM, Ntshoe GM, Suzuki M, Turner N, Hak E.

Lancet Respir Med. 2017 Mar;5(3):200-211. doi: 10.1016/S2213-2600(17)30043-7. Epub 2017 Feb 9.

PMID:
28189522
49.

Association of atopic diseases and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses.

Schans JV, Çiçek R, de Vries TW, Hak E, Hoekstra PJ.

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):139-148. doi: 10.1016/j.neubiorev.2017.01.011. Epub 2017 Jan 20. Review.

PMID:
28111269
50.

Exposure to reactive intermediate-inducing drugs during pregnancy and the incident use of psychotropic medications among children.

Tran YH, Groen H, Bergman JE, Hak E, Wilffert B.

Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):265-273. doi: 10.1002/pds.4161. Epub 2017 Jan 18.

PMID:
28097730

Supplemental Content

Support Center